Urogen Pharma Ltd (URGN)

SG&A Expense Growth

-5.92%

Quarterly · Period ending:

URGN logo

URGN SG&A Expense Growth

Latest reported-5.92%
URGN Quarterly SG&A Growth (QoQ) (0.00% → -5.92%)
High-resolution chart · PNG

URGN sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-5.922%
30.8445%
4.7017%
-13.0026%
23.5422%
0%
-100%
-3.7097%
10.0993%
11.193%
12.8522%
-3.2853%
-8.0902%
13.1275%
13.4393%
-8.4577%
-2.1925%
-0.5509%
0%
0%
0%
-100%
0%
-100%
9.3069%
11.2839%
41.3184%
1.4301%
8.4048%
1.2349%
16.8389%
5.2513%
68.1826%
76.5784%
56.2983%
-4.3913%
162.8571%
-28.8039%
-62.0327%
210.0575%
15.1047%
2.3702%
0%
-30.9609%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.